These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
523 related articles for article (PubMed ID: 16596254)
1. Non-muscle myosin heavy chain IIA and IIB interact and co-localize in living cells: relevance for MYH9-related disease. Marini M; Bruschi M; Pecci A; Romagnoli R; Musante L; Candiano G; Ghiggeri GM; Balduini C; Seri M; Ravazzolo R Int J Mol Med; 2006 May; 17(5):729-36. PubMed ID: 16596254 [TBL] [Abstract][Full Text] [Related]
2. Analysis of clinical manifestations, mutant gene and encoded protein in two Chinese MYH9-related disease families. Yi Y; Sen Zhang G; Xu M; San Ling Z; Ru Shao X; Zeng Li J; Ma J Clin Chim Acta; 2006 Nov; 373(1-2):49-54. PubMed ID: 16806139 [TBL] [Abstract][Full Text] [Related]
3. [Autosomal dominant macrothrombocytopenia with leukocyte inclusion bodies and MYH9 disorders]. Kunishima S Rinsho Byori; 2009 Apr; 57(4):365-70. PubMed ID: 19489439 [TBL] [Abstract][Full Text] [Related]
4. Haematological characteristics of MYH9 disorders due to MYH9 R702 mutations. Kunishima S; Yoshinari M; Nishio H; Ida K; Miura T; Matsushita T; Hamaguchi M; Saito H Eur J Haematol; 2007 Mar; 78(3):220-6. PubMed ID: 17241369 [TBL] [Abstract][Full Text] [Related]
5. [Expression and function of non-muscle myosin-IIA in Fechtner syndrome]. Yang HY; Wang ZY; Cao LJ; Zhao XJ; Bai X; Ruan CG Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):871-4. PubMed ID: 18718080 [TBL] [Abstract][Full Text] [Related]
6. MYH9-siRNA and MYH9 mutant alleles: expression in cultured cell lines and their effects upon cell structure and function. Li Y; Friedmann DR; Mhatre AN; Lalwani AK Cell Motil Cytoskeleton; 2008 May; 65(5):393-405. PubMed ID: 18330899 [TBL] [Abstract][Full Text] [Related]
7. Megakaryocytes of patients with MYH9-related thrombocytopenia present an altered proplatelet formation. Pecci A; Malara A; Badalucco S; Bozzi V; Torti M; Balduini CL; Balduini A Thromb Haemost; 2009 Jul; 102(1):90-6. PubMed ID: 19572073 [TBL] [Abstract][Full Text] [Related]
9. Expression of non-muscle type myosin heavy polypeptide 9 (MYH9) in mammalian cells. Takubo T; Wakui S; Daigo K; Kurokata K; Ohashi T; Katayama K; Hino M Eur J Histochem; 2003; 47(4):345-52. PubMed ID: 14706930 [TBL] [Abstract][Full Text] [Related]
10. Cloning of the murine non-muscle myosin heavy chain IIA gene ortholog of human MYH9 responsible for May-Hegglin, Sebastian, Fechtner, and Epstein syndromes. D'Apolito M; Guarnieri V; Boncristiano M; Zelante L; Savoia A Gene; 2002 Mar; 286(2):215-22. PubMed ID: 11943476 [TBL] [Abstract][Full Text] [Related]
11. Absence of hearing loss in a mouse model for DFNA17 and MYH9-related disease: the use of public gene-targeted ES cell resources. Parker LL; Gao J; Zuo J Brain Res; 2006 May; 1091(1):235-42. PubMed ID: 16630581 [TBL] [Abstract][Full Text] [Related]
12. Nonmuscle Myosin Heavy Chain IIA Mutation Predicts Severity and Progression of Sensorineural Hearing Loss in Patients With MYH9-Related Disease. Verver EJ; Topsakal V; Kunst HP; Huygen PL; Heller PG; Pujol-Moix N; Savoia A; Benazzo M; Fierro T; Grolman W; Gresele P; Pecci A Ear Hear; 2016; 37(1):112-20. PubMed ID: 26226608 [TBL] [Abstract][Full Text] [Related]
14. MYH9: Structure, functions and role of non-muscle myosin IIA in human disease. Pecci A; Ma X; Savoia A; Adelstein RS Gene; 2018 Jul; 664():152-167. PubMed ID: 29679756 [TBL] [Abstract][Full Text] [Related]
15. Signaling via the angiotensin-converting enzyme results in the phosphorylation of the nonmuscle myosin heavy chain IIA. Kohlstedt K; Kellner R; Busse R; Fleming I Mol Pharmacol; 2006 Jan; 69(1):19-26. PubMed ID: 16186248 [TBL] [Abstract][Full Text] [Related]
16. Identification of the first duplication in MYH9-related disease: a hot spot for unequal crossing-over within exon 24 of the MYH9 gene. De Rocco D; Pujol-Moix N; Pecci A; Faletra F; Bozzi V; Balduini CL; Savoia A Eur J Med Genet; 2009; 52(4):191-4. PubMed ID: 19450438 [TBL] [Abstract][Full Text] [Related]
17. Identification of the first in cis mutations in MYH9 disorder. Miyajima Y; Kunishima S Eur J Haematol; 2009 Apr; 82(4):288-91. PubMed ID: 19191864 [TBL] [Abstract][Full Text] [Related]
18. Clinical, pathological, and genetic analysis of ten patients with MYH9-related disease. Sun XH; Wang ZY; Yang HY; Cao LJ; Su J; Yu ZQ; Bai X; Ruan CG Acta Haematol; 2013; 129(2):106-13. PubMed ID: 23207509 [TBL] [Abstract][Full Text] [Related]
19. Targeted disruption of mouse ortholog of the human MYH9 responsible for macrothrombocytopenia with different organ involvement: hematological, nephrological, and otological studies of heterozygous KO mice. Matsushita T; Hayashi H; Kunishima S; Hayashi M; Ikejiri M; Takeshita K; Yuzawa Y; Adachi T; Hirashima K; Sone M; Yamamoto K; Takagi A; Katsumi A; Kawai K; Nezu T; Takahashi M; Nakashima T; Naoe T; Kojima T; Saito H Biochem Biophys Res Commun; 2004 Dec; 325(4):1163-71. PubMed ID: 15555549 [TBL] [Abstract][Full Text] [Related]